Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
100%(1 trials)

Phase Distribution

Ph not_applicable
3
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(1)
Other(2)

Detailed Status

unknown2
Completed1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

completed133%
unknown267%

Recent Activity

0 active trials
Showing 3 of 3
completednot_applicable

Automatic Self Transcending Meditation Versus Treatment as Usual

NCT02149810
unknownnot_applicable

Automatic Self Transcending Meditation (ASTM) Versus Usual Care in Patients With Glaucoma

NCT03086980
unknownnot_applicable

Automatic Self Transcending Meditation (ASTM) for Patients With Severe Age Related Macular Degeneration (AMD)

NCT03104608

Clinical Trials (3)

Showing 3 of 3 trials
NCT02149810Not Applicable

Automatic Self Transcending Meditation Versus Treatment as Usual

Completed
NCT03086980Not Applicable

Automatic Self Transcending Meditation (ASTM) Versus Usual Care in Patients With Glaucoma

Unknown
NCT03104608Not Applicable

Automatic Self Transcending Meditation (ASTM) for Patients With Severe Age Related Macular Degeneration (AMD)

Unknown

All 3 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
3